Trial Profile
Efficacy and safety of HMPL 004 in patients with mild-to-moderate ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2011
Price :
$35
*
At a glance
- Drugs HMPL 004 (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 11 Mar 2011 New trial record